Skip to content

Clinical trials

Phase 1 Lymphoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20102
20112
20121
20131
20141
20151
20175
20202
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
4SC AG2
Celgene2
Nordic Nanovector2
Bayer1
Boston Medical Center1
Eli Lilly and Company1
Hoffmann-La Roche1
Ludwig Institute for Cancer Research1
Novartis Vaccines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma19
Neoplasms5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Non-Hodgkin4
Lymphoma, Large B-Cell, Diffuse3
Multiple Myeloma3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
AIDS-Related Complex2
Hodgkin Disease2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.